StockTipsArenaBeta

BUY Aarti Drugs Limited — Sahi Research

BUYAarti Drugs Limited
Aarti Drugs share price target & all analyst calls

bySahi ResearchHorizon: NA (inferred Swing (≤2wk))24 Aug 2026via Sahi Research Telegram

Entry₹421.5Stated
Target₹438
Total upside +3.91% (call closed)
Stop loss₹410-2.73% risk
Exit₹41031 Aug 2026, 3:20 pm
Stop-loss hit-2.73%
Follow Sahi Research for new calls(29% target hit, 120 closed calls)Get alertsWatch AARTIDRUGS for new buy/sell callsGet alertsSee 126 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 31 Aug 2026
2 supporting1 neutral1 opposing
Supports the BUY call (2)

Aarti Drugs Ltd's Board of Directors has approved the company's Performance Stock Option Plan 2026. This plan is likely to incentivize employees and align their interests with the company's performanc

BSE · Board Meeting·27 Aug · 4d ago

(opens in new tab)

Aarti Drugs Targets 15-16% EBITDA Margin On Higher Sayakha Utilisation, Metformin Volumes: CFO

NewsNdtv-Profit·24 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (1)

The Board of Directors approved the 'Aarti Drugs Limited Performance Stock Option Plan 2026' to create and grant up to 8,00,000 stock options convertible into equity shares. This is subject to member

NSE · Outcome of Board Meeting·27 Aug · 4d ago

(opens in new tab)
Weighs against the BUY call (1)

Aarti Drugs Limited has disclosed pending litigation or disputes that may impact the company's operations or financial standing.

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·10 Aug · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aarti Drugs

All analyst calls on Aarti Drugs

More from Sahi Research

Every call and its outcome